Cutaneous Hydration Assessment in SCD
Recruiting · NCT05210114 · Interventional (participants receive a specific treatment) · Lead sponsor: Enrico Novelli
View the official record on ClinicalTrials.gov →Interventions studied
Skin Hydration Sensor
What this trial is about
This study will validate the diagnostic accuracy of a cutaneous hydration sensor. This sensor will also be evaluated for its feasibility as a point-of-care device for the assessment of hydration status and its potential to guide hydration therapy in patients with sickle cell disease (SCD).
Who can take part
Age range
12 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- Diagnosis of Sickle Cell Disease (genotypes SS, SC, Sß-thalassemia, SD, SOArab)
- Participants must be ≥12-years old
- Participants that provide legally effective consent to all study procedures
Exclusion criteria
- Participants under 12-years old
- Participants being treated with experimental therapies in clinical trials
Where it is running
1 location listed across 1 US state.
- UPMC Sickle Cell Clinic - Pittsburgh, Pennsylvania, United States